Although ultrahigh-pressure liquid chromatography (UHPLC) method development is fast and cost efficient, many of the analytical methods used in quality control laboratories are still conventional high performance LC (HPLC) separations. Transferring these HPLC methods to UHPLC and validating them is a time-consuming and labour-intensive task. Nevertheless, switching methods from HPLC to UHPLC equipment and vice versa is a powerful tool to increase laboratory efficiency. Modern systems with two flow lines in one system aim to simplify the transition between the two techniques.
Photo Credit: Gines Valera Marin/Shutterstock.com
Gesa Schad, Shimadzu, Duisburg, Germany
Although ultrahigh-pressure liquid chromatography (UHPLC) method development is fast and cost efficient, many of the analytical methods used in quality control laboratories are still conventional high performance LC (HPLC) separations. Transferring these HPLC methods to UHPLC and validating them is a time-consuming and labour-intensive task. Nevertheless, switching methods from HPLC to UHPLC equipment and vice versa is a powerful tool to increase laboratory efficiency. Modern systems with two flow lines in one system aim to simplify the transition between the two techniques.
In recent years, there has been a strong focus on the use of ultrahigh-pressure liquid chromatography (UHPLC) instruments and small particle columns to develop faster and better analytical methods to improve efficiency and throughput, especially in R&D environments. Yet many of the analytical methods used in quality control laboratories, including those listed in the Pharmacopoeia, are conventional high performance LC (HPLC) methods. Transferring these HPLC methods to UHPLC and validating the new methods is a time-consuming and labourâintensive task, which is why many companies don’t do it.
However, new method development has to be faster and more cost efficient, so UHPLC equipment is often used. After high-throughput screening, identification, and optimization of the final method, the separation conditions are transferred back to normal HPLC mode to be run in the QA/QC departments that still prefer the robust and reliable HPLC equipment. This method transfer poses some problems because of differences in system volume and therefore gradient delay. The gradient delay volume causes an isocratic hold before the beginning of the gradient, which affects the separation selectivity. It can differ from system to system and therefore complicates the transfer of a gradient method from one system to another.
Straightforward Method Transfer
With the rise of UHPLC and the objective of faster, more efficient separation methods, chromatographers face the challenge of transferring routine HPLC methods to UHPLC equipment, or methods developed on a UHPLC screening system to HPLC instruments for routine use. Just like any other task, method transfer to a different instrument and different column dimensions is fairly straightforward when done in accordance with a few simple rules. UHPLC equipment has to withstand higher pressures and the system volume is optimized for minimum gradient delay and extracolumn band broadening.
HPLC instruments are designed to work at a pressure no higher than 400 bar, so column dimensions of 150 or 250 × 4.6 mm with a flow rate of 1 mL/min and particle sizes of 5- or 3-µm are used. These conditions allow for peek tubing with an inner diameter of 0.3 mm (blue) because system and gradient delay volume are not crucial factors with high flow rates and long gradient times (see Figure 1).
Hybrid Options
Hybrid systems are available that incorporate two analytical flow lines with different system volumes in a single instrument. By switching between these flowlines, both HPLC and UHPLC analyses can be performed with the same system. The relative separation pattern is preserved by software that adjusts the gradient conditions according to changes in flow rate and column dimensions, and enable automated compensation for differences in system volume.
This technology helps less experienced users in any method transfer efforts, and also allows existing HPLC or UHPLC methods run on any other instrument platform to be matched, eliminating the need to consider and carefully adjust tubing lengths to achieve identical system volumes between instruments.
Experimental
Method Conditions: Column: 150 × 4.6 mm ACE Excel 3 SuperC18 (ACT); mobile phase: A: 0.1% formic acid in H2O; B: 0.1% formic acid in MeCN; gradient programme: time: 0 min, % B: 20; time: 20 min, % B: 70; time: 25 min, % B: 70. This was followed by 11 min reâequilibration time (20 %B) 36 min run time; flow rate: 1 mL/min; temperature: 40 °C; detection at: 254 nm; sample: 0.6 mg aspirin, 0.1 mg sulindac and 0.2 mg of naproxen, flurbiprofen, phenylbutazone in 1 mL acetonitrile–water (50:50 v/v); system: Nexera-i MT method transfer system with photo diode array detector (Shimadzu).
Method Transfer
When transferring an HPLC method to a UHPLC system or vice versa, care must be taken to maintain selectivity when changing column dimensions and flow rate. In a gradient separation the crucial factor is the relative retention factor (k*) that is influenced by gradient time (tg), flow rate (F), change in organic solvent (â%B), column dead volume (V0), and a constant (S) according to:
[1]
The relative retention factor (k*) must be kept constant, and so gradient time has to be adjusted when column dimensions or flow rate are changed. However, other parameters, such as injection volume or detector capture rate, also need to be adjusted when looking to use a smaller column or increase the speed of the analysis. The new method is calculated based on original method parameters and the new column and flow rate information (Figure 2).
The example shows the successful transfer from a 36-min HPLC method to a 7-min separation in UHPLC conditions, where gradient time, column dimensions, and flow rate were adjusted to maintain selectivity in the faster analysis (Figure 3 [b–c]). It doesn’t take an expert chromatographer to perform this kind of increase in efficiency.
Conclusion
The transfer of HPLC methods to UHPLC equipment and vice versa is a powerful tool to increase laboratory efficiency or to allow high speed method development of methods that have to be run on HPLC equipment. However, when changing from one to the other, care must be taken to consider the differences in the two techniques. Systems with two flow lines in one system can simplify the method transition process and avoid problems associated with gradient delay.
Gesa Johanna Schad graduated with a Diploma in chemical engineering from the Technical University NTA in Isny, Germany, in 2004 and as a Master of Science in pharmaceutical analysis from the University of Strathclyde in Glasgow, UK, in 2005. Worked until 2006 as a consultant in HPLC method development and validation in an analytical laboratory of the FAO/IAEA in Vienna, Austria. She gained her doctorate for research in pharmaceutical sciences at the University of Strathclyde in 2010 and was employed as HPLC specialist in the R&D department at Hichrom Ltd. in Reading, UK from 2009. Since 2013, she worked as a HPLC product specialist and since 2015 as HPLC Product Manager in the analytical business unit of Shimadzu Europa in Duisburg, Germany.
E-mail:shimadzu@shimadzu.euWebsite:www.shimadzu.eu
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.